Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 421 to 431 of 431 entries
Sorted by: Best Match Show Resources per page
Ultrasound guided catheter tip location in neonates: a prospective cohort study.

The Journal of pediatrics

Grasso F, Capasso A, Pacella D, Borgia F, Salomè S, Capasso L, Raimondi F.
PMID: 34971654
J Pediatr. 2021 Dec 28; doi: 10.1016/j.jpeds.2021.12.059. Epub 2021 Dec 28.

OBJECTIVE: To assess Point of Care Ultrasound (POCUS) guided catheter tip location in a neonatal cohort after insertion of percutaneously inserted central catheters (PICCs) from the upper part of the body.STUDY DESIGN: This was a prospective, observational study on...

Cite
Grasso F, Capasso A, Pacella D, et al. Ultrasound guided catheter tip location in neonates: a prospective cohort study. J Pediatr. 2021;doi: 10.1016/j.jpeds.2021.12.059.
Grasso, F., Capasso, A., Pacella, D., Borgia, F., Salomè, S., Capasso, L., & Raimondi, F. (2021). Ultrasound guided catheter tip location in neonates: a prospective cohort study. The Journal of pediatrics, . https://doi.org/10.1016/j.jpeds.2021.12.059
Grasso, Fiorentino, et al. "Ultrasound guided catheter tip location in neonates: a prospective cohort study." The Journal of pediatrics vol. (2021). doi: https://doi.org/10.1016/j.jpeds.2021.12.059
Grasso F, Capasso A, Pacella D, Borgia F, Salomè S, Capasso L, Raimondi F. Ultrasound guided catheter tip location in neonates: a prospective cohort study. J Pediatr. 2021 Dec 28; doi: 10.1016/j.jpeds.2021.12.059. Epub 2021 Dec 28. PMID: 34971654.
Copy Download .nbib Format: NLM
Cardiovascular Involvement in COVID-19: What Sequelae Should We Expect?.

Cardiology and therapy

Polito MV, Silverio A, Bellino M, Iuliano G, Di Maio M, Alfano C, Iannece P, Esposito N, Galasso G.
PMID: 34191268
Cardiol Ther. 2021 Dec;10(2):377-396. doi: 10.1007/s40119-021-00232-8. Epub 2021 Jun 30.

Several forms of cardiovascular involvement have been described in patients with Coronavirus disease 19 (COVID-19): myocardial injury, acute coronary syndrome, acute heart failure, myocarditis, pericardial diseases, arrhythmias, takotsubo syndrome, and arterial and venous atherothrombotic and thromboembolic events. Data on...

Cite
Polito MV, Silverio A, Bellino M, et al. Cardiovascular Involvement in COVID-19: What Sequelae Should We Expect?. Cardiol Ther. 2021;10(2):377-396doi: 10.1007/s40119-021-00232-8.
Polito, M. V., Silverio, A., Bellino, M., Iuliano, G., Di Maio, M., Alfano, C., Iannece, P., Esposito, N., & Galasso, G. (2021). Cardiovascular Involvement in COVID-19: What Sequelae Should We Expect?. Cardiology and therapy, 10(2), 377-396. https://doi.org/10.1007/s40119-021-00232-8
Polito, Maria Vincenza, et al. "Cardiovascular Involvement in COVID-19: What Sequelae Should We Expect?." Cardiology and therapy vol. 10,2 (2021): 377-396. doi: https://doi.org/10.1007/s40119-021-00232-8
Polito MV, Silverio A, Bellino M, Iuliano G, Di Maio M, Alfano C, Iannece P, Esposito N, Galasso G. Cardiovascular Involvement in COVID-19: What Sequelae Should We Expect?. Cardiol Ther. 2021 Dec;10(2):377-396. doi: 10.1007/s40119-021-00232-8. Epub 2021 Jun 30. PMID: 34191268; PMCID: PMC8243311.
Copy Download .nbib Format: NLM
Definitions and Clinical Trial Design Principles for Coronary Artery Chronic Total Occlusion Therapies: CTO-ARC Consensus Recommendations.

Circulation

Ybarra LF, Rinfret S, Brilakis ES, Karmpaliotis D, Azzalini L, Grantham JA, Kandzari DE, Mashayekhi K, Spratt JC, Wijeysundera HC, Ali ZA, Buller CE, Carlino M, Cohen DJ, Cutlip DE, De Martini T, Di Mario C, Farb A, Finn AV, Galassi AR, Gibson CM, Hanratty C, Hill JM, Jaffer FA, Krucoff MW, Lombardi WL, Maehara A, Magee PFA, Mehran R, Moses JW, Nicholson WJ, Onuma Y, Sianos G, Sumitsuji S, Tsuchikane E, Virmani R, Walsh SJ, Werner GS, Yamane M, Stone GW, Rinfret S, Stone GW.
PMID: 33523728
Circulation. 2021 Feb 02;143(5):479-500. doi: 10.1161/CIRCULATIONAHA.120.046754. Epub 2021 Feb 01.

Over the past 2 decades, chronic total occlusion (CTO) percutaneous coronary intervention has developed into its own subspecialty of interventional cardiology. Dedicated terminology, techniques, devices, courses, and training programs have enabled progressive advancements. However, only a few randomized trials...

Cite
Ybarra LF, Rinfret S, Brilakis ES, et al. Definitions and Clinical Trial Design Principles for Coronary Artery Chronic Total Occlusion Therapies: CTO-ARC Consensus Recommendations. Circulation. 2021;143(5):479-500doi: 10.1161/CIRCULATIONAHA.120.046754.
Ybarra, L. F., Rinfret, S., Brilakis, E. S., Karmpaliotis, D., Azzalini, L., Grantham, J. A., Kandzari, D. E., Mashayekhi, K., Spratt, J. C., Wijeysundera, H. C., Ali, Z. A., Buller, C. E., Carlino, M., Cohen, D. J., Cutlip, D. E., De Martini, T., Di Mario, C., Farb, A., Finn, A. V., Galassi, A. R., Gibson, C. M., Hanratty, C., Hill, J. M., Jaffer, F. A., Krucoff, M. W., Lombardi, W. L., Maehara, A., Magee, P. F. A., Mehran, R., Moses, J. W., Nicholson, W. J., Onuma, Y., Sianos, G., Sumitsuji, S., Tsuchikane, E., Virmani, R., Walsh, S. J., Werner, G. S., Yamane, M., Stone, G. W., Rinfret, S., Stone, G. W. (2021). Definitions and Clinical Trial Design Principles for Coronary Artery Chronic Total Occlusion Therapies: CTO-ARC Consensus Recommendations. Circulation, 143(5), 479-500. https://doi.org/10.1161/CIRCULATIONAHA.120.046754
Ybarra, Luiz F, et al. "Definitions and Clinical Trial Design Principles for Coronary Artery Chronic Total Occlusion Therapies: CTO-ARC Consensus Recommendations." Circulation vol. 143,5 (2021): 479-500. doi: https://doi.org/10.1161/CIRCULATIONAHA.120.046754
Ybarra LF, Rinfret S, Brilakis ES, Karmpaliotis D, Azzalini L, Grantham JA, Kandzari DE, Mashayekhi K, Spratt JC, Wijeysundera HC, Ali ZA, Buller CE, Carlino M, Cohen DJ, Cutlip DE, De Martini T, Di Mario C, Farb A, Finn AV, Galassi AR, Gibson CM, Hanratty C, Hill JM, Jaffer FA, Krucoff MW, Lombardi WL, Maehara A, Magee PFA, Mehran R, Moses JW, Nicholson WJ, Onuma Y, Sianos G, Sumitsuji S, Tsuchikane E, Virmani R, Walsh SJ, Werner GS, Yamane M, Stone GW, Rinfret S, Stone GW. Definitions and Clinical Trial Design Principles for Coronary Artery Chronic Total Occlusion Therapies: CTO-ARC Consensus Recommendations. Circulation. 2021 Feb 02;143(5):479-500. doi: 10.1161/CIRCULATIONAHA.120.046754. Epub 2021 Feb 01. PMID: 33523728.
Copy Download .nbib Format: NLM
ESDN inhibits melanoma progression by blocking E-selectin expression in endothelial cells via STAT3.

Cancer letters

Coppo R, Orso F, Virga F, Dalmasso A, Baruffaldi D, Nie L, Clapero F, Dettori D, Quirico L, Grassi E, Defilippi P, Provero P, Valdembri D, Serini G, Sadeghi MM, Mazzone M, Taverna D.
PMID: 33862151
Cancer Lett. 2021 Jul 10;510:13-23. doi: 10.1016/j.canlet.2021.04.005. Epub 2021 Apr 13.

An interactive crosstalk between tumor and stroma cells is essential for metastatic melanoma progression. We evidenced that ESDN/DCBLD2/CLCP1 plays a crucial role in endothelial cells during the spread of melanoma. Precisely, increased extravasation and metastasis formation were revealed in...

Cite
Coppo R, Orso F, Virga F, et al. ESDN inhibits melanoma progression by blocking E-selectin expression in endothelial cells via STAT3. Cancer Lett. 2021;510:13-23doi: 10.1016/j.canlet.2021.04.005.
Coppo, R., Orso, F., Virga, F., Dalmasso, A., Baruffaldi, D., Nie, L., Clapero, F., Dettori, D., Quirico, L., Grassi, E., Defilippi, P., Provero, P., Valdembri, D., Serini, G., Sadeghi, M. M., Mazzone, M., & Taverna, D. (2021). ESDN inhibits melanoma progression by blocking E-selectin expression in endothelial cells via STAT3. Cancer letters, 51013-23. https://doi.org/10.1016/j.canlet.2021.04.005
Coppo, Roberto, et al. "ESDN inhibits melanoma progression by blocking E-selectin expression in endothelial cells via STAT3." Cancer letters vol. 510 (2021): 13-23. doi: https://doi.org/10.1016/j.canlet.2021.04.005
Coppo R, Orso F, Virga F, Dalmasso A, Baruffaldi D, Nie L, Clapero F, Dettori D, Quirico L, Grassi E, Defilippi P, Provero P, Valdembri D, Serini G, Sadeghi MM, Mazzone M, Taverna D. ESDN inhibits melanoma progression by blocking E-selectin expression in endothelial cells via STAT3. Cancer Lett. 2021 Jul 10;510:13-23. doi: 10.1016/j.canlet.2021.04.005. Epub 2021 Apr 13. PMID: 33862151; PMCID: PMC8581997.
Copy Download .nbib Format: NLM
Bronchoscopy during COVID-19 pandemic, ventilatory strategies and procedure measures.

Panminerva medica

Patrucco F, Failla G, Ferrari G, Galasso T, Candoli P, Mondoni M, Piro R, Facciolongo NC, Renda T, Salio M, Scala R, Solidoro P, Mattei A, Donato P, Vaschetto R, Balbo PE.
PMID: 34606187
Panminerva Med. 2021 Dec;63(4):529-538. doi: 10.23736/S0031-0808.21.04533-X. Epub 2021 Oct 04.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has changed bronchoscopy practices worldwide. Bronchoscopy is a high-risk aerosol-generating procedure with a potential for direct SARS-CoV-2 exposure and hospital-acquired infection. Current guidelines about personal protective equipment and environment considerations represent...

Cite
Patrucco F, Failla G, Ferrari G, et al. Bronchoscopy during COVID-19 pandemic, ventilatory strategies and procedure measures. Panminerva Med. 2021;63(4):529-538doi: 10.23736/S0031-0808.21.04533-X.
Patrucco, F., Failla, G., Ferrari, G., Galasso, T., Candoli, P., Mondoni, M., Piro, R., Facciolongo, N. C., Renda, T., Salio, M., Scala, R., Solidoro, P., Mattei, A., Donato, P., Vaschetto, R., Balbo, P. E. (2021). Bronchoscopy during COVID-19 pandemic, ventilatory strategies and procedure measures. Panminerva medica, 63(4), 529-538. https://doi.org/10.23736/S0031-0808.21.04533-X
Patrucco, Filippo, et al. "Bronchoscopy during COVID-19 pandemic, ventilatory strategies and procedure measures." Panminerva medica vol. 63,4 (2021): 529-538. doi: https://doi.org/10.23736/S0031-0808.21.04533-X
Patrucco F, Failla G, Ferrari G, Galasso T, Candoli P, Mondoni M, Piro R, Facciolongo NC, Renda T, Salio M, Scala R, Solidoro P, Mattei A, Donato P, Vaschetto R, Balbo PE. Bronchoscopy during COVID-19 pandemic, ventilatory strategies and procedure measures. Panminerva Med. 2021 Dec;63(4):529-538. doi: 10.23736/S0031-0808.21.04533-X. Epub 2021 Oct 04. PMID: 34606187.
Copy Download .nbib Format: NLM
A Case of Frontotemporal Lobar Degeneration With FUS-Positive Pathology (FTLD-FET) With Corticobasal Features and Language Deficits.

Journal of neuropathology and experimental neurology

Goodwill V, Coughlin D, Pizzo D, Galasko D, Hansen LA, Yuan SH, Hiniker A.
PMID: 33969424
J Neuropathol Exp Neurol. 2021 Sep 27;80(9):890-892. doi: 10.1093/jnen/nlab034.

No abstract available.

Cite
Goodwill V, Coughlin D, Pizzo D, et al. A Case of Frontotemporal Lobar Degeneration With FUS-Positive Pathology (FTLD-FET) With Corticobasal Features and Language Deficits. J Neuropathol Exp Neurol. 2021;80(9):890-892doi: 10.1093/jnen/nlab034.
Goodwill, V., Coughlin, D., Pizzo, D., Galasko, D., Hansen, L. A., Yuan, S. H., & Hiniker, A. (2021). A Case of Frontotemporal Lobar Degeneration With FUS-Positive Pathology (FTLD-FET) With Corticobasal Features and Language Deficits. Journal of neuropathology and experimental neurology, 80(9), 890-892. https://doi.org/10.1093/jnen/nlab034
Goodwill, Vanessa, et al. "A Case of Frontotemporal Lobar Degeneration With FUS-Positive Pathology (FTLD-FET) With Corticobasal Features and Language Deficits." Journal of neuropathology and experimental neurology vol. 80,9 (2021): 890-892. doi: https://doi.org/10.1093/jnen/nlab034
Goodwill V, Coughlin D, Pizzo D, Galasko D, Hansen LA, Yuan SH, Hiniker A. A Case of Frontotemporal Lobar Degeneration With FUS-Positive Pathology (FTLD-FET) With Corticobasal Features and Language Deficits. J Neuropathol Exp Neurol. 2021 Sep 27;80(9):890-892. doi: 10.1093/jnen/nlab034. PMID: 33969424; PMCID: PMC8476078.
Copy Download .nbib Format: NLM
Predictors of outcome in patients with myasthenic crisis undergoing non-invasive mechanical ventilation: A retrospective 20 year longitudinal cohort study from a single Italian center.

Neuromuscular disorders : NMD

Iori E, Mazzoli M, Ariatti A, Bastia E, Agnoletto V, Gozzi M, Marchioni A, Galassi G.
PMID: 34782245
Neuromuscul Disord. 2021 Dec;31(12):1241-1250. doi: 10.1016/j.nmd.2021.08.008. Epub 2021 Aug 20.

About 20% of patients with myasthenia gravis (MG) may develop myasthenic crisis (MC) requiring ventilation, either invasive (MV) or non-invasive (NIV) and intensive unit care (ICU). NIV failure in patients with MC can occur up to 60% of cases...

Cite
Iori E, Mazzoli M, Ariatti A, et al. Predictors of outcome in patients with myasthenic crisis undergoing non-invasive mechanical ventilation: A retrospective 20 year longitudinal cohort study from a single Italian center. Neuromuscul Disord. 2021;31(12):1241-1250doi: 10.1016/j.nmd.2021.08.008.
Iori, E., Mazzoli, M., Ariatti, A., Bastia, E., Agnoletto, V., Gozzi, M., Marchioni, A., & Galassi, G. (2021). Predictors of outcome in patients with myasthenic crisis undergoing non-invasive mechanical ventilation: A retrospective 20 year longitudinal cohort study from a single Italian center. Neuromuscular disorders : NMD, 31(12), 1241-1250. https://doi.org/10.1016/j.nmd.2021.08.008
Iori, Erika, et al. "Predictors of outcome in patients with myasthenic crisis undergoing non-invasive mechanical ventilation: A retrospective 20 year longitudinal cohort study from a single Italian center." Neuromuscular disorders : NMD vol. 31,12 (2021): 1241-1250. doi: https://doi.org/10.1016/j.nmd.2021.08.008
Iori E, Mazzoli M, Ariatti A, Bastia E, Agnoletto V, Gozzi M, Marchioni A, Galassi G. Predictors of outcome in patients with myasthenic crisis undergoing non-invasive mechanical ventilation: A retrospective 20 year longitudinal cohort study from a single Italian center. Neuromuscul Disord. 2021 Dec;31(12):1241-1250. doi: 10.1016/j.nmd.2021.08.008. Epub 2021 Aug 20. PMID: 34782245.
Copy Download .nbib Format: NLM
Comment on case series of COVID-19 in patients with myasthenia gravis: a single institution experience by Županić et al.

Acta neurologica Belgica

Galassi G, Marchioni A.
PMID: 34608594
Acta Neurol Belg. 2021 Oct 04; doi: 10.1007/s13760-021-01746-7. Epub 2021 Oct 04.

No abstract available.

Cite
Galassi G, Marchioni A. Comment on case series of COVID-19 in patients with myasthenia gravis: a single institution experience by Županić et al. Acta Neurol Belg. 2021;doi: 10.1007/s13760-021-01746-7.
Galassi, G., & Marchioni, A. (2021). Comment on case series of COVID-19 in patients with myasthenia gravis: a single institution experience by Županić et al. Acta neurologica Belgica, . https://doi.org/10.1007/s13760-021-01746-7
Galassi, Giuliana, and Marchioni, Alessandro. "Comment on case series of COVID-19 in patients with myasthenia gravis: a single institution experience by Županić et al." Acta neurologica Belgica vol. (2021). doi: https://doi.org/10.1007/s13760-021-01746-7
Galassi G, Marchioni A. Comment on case series of COVID-19 in patients with myasthenia gravis: a single institution experience by Županić et al. Acta Neurol Belg. 2021 Oct 04; doi: 10.1007/s13760-021-01746-7. Epub 2021 Oct 04. PMID: 34608594; PMCID: PMC8489789.
Copy Download .nbib Format: NLM
Total neoadjuvant therapy for initially inoperable pancreatic cancer: A systematic review of phase 2-3 studies.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Tomasello G, Ghidini M, Ghidini A, Trevisan F, Celotti A, Russo A, Gambini D, Indini A, Rijavec E, Bareggi C, Galassi B, Petrelli F.
PMID: 34509562
Radiother Oncol. 2021 Nov;164:13-19. doi: 10.1016/j.radonc.2021.09.001. Epub 2021 Sep 10.

INTRODUCTION: Patients with initially inoperable non-metastatic pancreatic cancer (PC) have a poor prognosis, often similar to those with metastatic disease. Neoadjuvant chemotherapy (CT) plus concomitant or sequential radiotherapy (RT) may cause tumor shrinkage and allow for radical surgery. We...

Cite
Tomasello G, Ghidini M, Ghidini A, et al. Total neoadjuvant therapy for initially inoperable pancreatic cancer: A systematic review of phase 2-3 studies. Radiother Oncol. 2021;164:13-19doi: 10.1016/j.radonc.2021.09.001.
Tomasello, G., Ghidini, M., Ghidini, A., Trevisan, F., Celotti, A., Russo, A., Gambini, D., Indini, A., Rijavec, E., Bareggi, C., Galassi, B., & Petrelli, F. (2021). Total neoadjuvant therapy for initially inoperable pancreatic cancer: A systematic review of phase 2-3 studies. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 16413-19. https://doi.org/10.1016/j.radonc.2021.09.001
Tomasello, Gianluca, et al. "Total neoadjuvant therapy for initially inoperable pancreatic cancer: A systematic review of phase 2-3 studies." Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology vol. 164 (2021): 13-19. doi: https://doi.org/10.1016/j.radonc.2021.09.001
Tomasello G, Ghidini M, Ghidini A, Trevisan F, Celotti A, Russo A, Gambini D, Indini A, Rijavec E, Bareggi C, Galassi B, Petrelli F. Total neoadjuvant therapy for initially inoperable pancreatic cancer: A systematic review of phase 2-3 studies. Radiother Oncol. 2021 Nov;164:13-19. doi: 10.1016/j.radonc.2021.09.001. Epub 2021 Sep 10. PMID: 34509562.
Copy Download .nbib Format: NLM
A Fibre- vs. cereal grain-based diet: Which is better for horse welfare? Effects on intestinal permeability, muscle characteristics and oxidative status in horses reared for meat production.

Journal of animal physiology and animal nutrition

Raspa F, Dinardo FR, Vervuert I, Bergero D, Bottero MT, Pattono D, Dalmasso A, Vinassa M, Valvassori E, Bruno E, De Palo P, Valle E.
PMID: 34553422
J Anim Physiol Anim Nutr (Berl). 2021 Sep 22; doi: 10.1111/jpn.13643. Epub 2021 Sep 22.

Horses reared for meat production are fed high amounts of cereal grains in comparison with horses raised for other purposes. Such feeding practice may lead to risk of poor welfare consequences. The aim of this study was to investigate...

Cite
Raspa F, Dinardo FR, Vervuert I, et al. A Fibre- vs. cereal grain-based diet: Which is better for horse welfare? Effects on intestinal permeability, muscle characteristics and oxidative status in horses reared for meat production. J Anim Physiol Anim Nutr (Berl). 2021;doi: 10.1111/jpn.13643.
Raspa, F., Dinardo, F. R., Vervuert, I., Bergero, D., Bottero, M. T., Pattono, D., Dalmasso, A., Vinassa, M., Valvassori, E., Bruno, E., De Palo, P., & Valle, E. (2021). A Fibre- vs. cereal grain-based diet: Which is better for horse welfare? Effects on intestinal permeability, muscle characteristics and oxidative status in horses reared for meat production. Journal of animal physiology and animal nutrition, . https://doi.org/10.1111/jpn.13643
Raspa, Federica, et al. "A Fibre- vs. cereal grain-based diet: Which is better for horse welfare? Effects on intestinal permeability, muscle characteristics and oxidative status in horses reared for meat production." Journal of animal physiology and animal nutrition vol. (2021). doi: https://doi.org/10.1111/jpn.13643
Raspa F, Dinardo FR, Vervuert I, Bergero D, Bottero MT, Pattono D, Dalmasso A, Vinassa M, Valvassori E, Bruno E, De Palo P, Valle E. A Fibre- vs. cereal grain-based diet: Which is better for horse welfare? Effects on intestinal permeability, muscle characteristics and oxidative status in horses reared for meat production. J Anim Physiol Anim Nutr (Berl). 2021 Sep 22; doi: 10.1111/jpn.13643. Epub 2021 Sep 22. PMID: 34553422.
Copy Download .nbib Format: NLM
Profiles of liver fibrosis evolution during long-term tenofovir treatment in HIV-positive patients coinfected with hepatitis B.

Liver international : official journal of the International Association for the Study of the Liver

Dezanet LNC, Miailhes P, Lascoux-Combe C, Chas J, Maylin S, Gabassi A, Rougier H, Delaugerre C, Lacombe K, Boyd A.
PMID: 34297463
Liver Int. 2021 Jul 23; doi: 10.1111/liv.15019. Epub 2021 Jul 23.

BACKGROUND & AIMS: Data on liver fibrosis evolution and its involvement in liver-related morbidity are scarce in individuals with human immunodeficiency virus (HIV) and hepatitis B virus (HBV) co-infection during treatment. We identified profiles of liver fibrosis evolution in...

Cite
Dezanet LNC, Miailhes P, Lascoux-Combe C, et al. Profiles of liver fibrosis evolution during long-term tenofovir treatment in HIV-positive patients coinfected with hepatitis B. Liver Int. 2021;doi: 10.1111/liv.15019.
Dezanet, L. N. C., Miailhes, P., Lascoux-Combe, C., Chas, J., Maylin, S., Gabassi, A., Rougier, H., Delaugerre, C., Lacombe, K., & Boyd, A. (2021). Profiles of liver fibrosis evolution during long-term tenofovir treatment in HIV-positive patients coinfected with hepatitis B. Liver international : official journal of the International Association for the Study of the Liver, . https://doi.org/10.1111/liv.15019
Dezanet, Lorenza N C, et al. "Profiles of liver fibrosis evolution during long-term tenofovir treatment in HIV-positive patients coinfected with hepatitis B." Liver international : official journal of the International Association for the Study of the Liver vol. (2021). doi: https://doi.org/10.1111/liv.15019
Dezanet LNC, Miailhes P, Lascoux-Combe C, Chas J, Maylin S, Gabassi A, Rougier H, Delaugerre C, Lacombe K, Boyd A. Profiles of liver fibrosis evolution during long-term tenofovir treatment in HIV-positive patients coinfected with hepatitis B. Liver Int. 2021 Jul 23; doi: 10.1111/liv.15019. Epub 2021 Jul 23. PMID: 34297463.
Copy Download .nbib Format: NLM
Showing 421 to 431 of 431 entries